Irene B.
- Country
- The Netherlands
- Department
- 40838: Rheumatology & Clinical Immunology
Research Overview
- Long-Term Safety and Tolerability Assessment of Dapirolizumab Pegol in Patients with Systemic Lupus Erythematosus: A Multicenter, Open-Label Extension Study
- Evaluation of Dapirolizumab Pegol Efficacy and Safety in Moderately to Severely Active Systemic Lupus Erythematosus: A Randomized, Double-Blind, Placebo-Controlled Study
Data & Insights
Has run more than one trial at 65 of 93 partner sites.
Specializations
Autoimmune Disease Research
The investigator specializes in the study of systemic lupus erythematosus (SLE), focusing on developing innovative therapeutic approaches for patients with moderate to severe disease manifestations.
- Lupus Management Strategies
- Advanced Treatment Protocols
- Disease Activity Assessment
Their research centers on evaluating novel therapeutic agents in combination with standard care treatments for autoimmune conditions.
Clinical Immunology
The investigator's work encompasses the examination of immune system modulation in autoimmune disorders, with particular attention to long-term disease management approaches.
- Immunological Response Patterns
- Therapeutic Efficacy Assessment
- Treatment Safety Evaluation
Their expertise extends to investigating targeted biological therapies for immune-mediated diseases.
Therapeutic Innovation
The investigator focuses on advancing add-on treatment strategies for patients with autoimmune conditions who require enhanced therapeutic options beyond standard care.
- Novel Treatment Development
- Clinical Response Monitoring
- Patient Care Optimization
Their research aims to expand treatment options for patients with challenging autoimmune manifestations.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.